Tuesday, January 23, 2018

Bioverativ Inc. (BIVV) Vaulted To A New High After Bought By Sanofi

Bioverativ Inc. (BIVV) announced Monday morning that it has agreed to be acquired by Sanofi for $105 per share in cash, approximately $11.6 billion.

from RTT - Before the Bell http://ift.tt/2G9cwaA
via IFTTT

No comments:

Post a Comment